Max Planck Laboratory for Structural Biology, Chemistry and Molecular Biophysics of Rosario (MPLbioR, UNR-MPIbpC) and Instituto de Investigaciones para el Descubrimiento de Fármacos de Rosario (IIDEFAR, UNR-CONICET), Universidad Nacional de Rosario, Ocampo y Esmeralda, S2002LRK, Rosario, Argentina.
Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San Luis, Chacabuco y Pedernera, CP 5700, San Luis, Argentina.
J Biol Inorg Chem. 2019 Dec;24(8):1269-1278. doi: 10.1007/s00775-019-01711-z. Epub 2019 Sep 5.
The discovery of aggregation inhibitors and the elucidation of their mechanism of action are key in the quest to mitigate the toxic consequences of amyloid formation. We have previously characterized the antiamyloidogenic mechanism of action of sodium phtalocyanine tetrasulfonate ([Na(HPcTS)]) on α-Synuclein (αS), demonstrating that specific aromatic interactions are fundamental for the inhibition of amyloid assembly. Here we studied the influence that metal preferential affinity and peripheral substituents may have on the activity of tetrapyrrolic compounds on αS aggregation. For the first time, our laboratory has extended the studies in the field of the bioinorganic chemistry and biophysics to cellular biology, using a well-established cell-based model to study αS aggregation. The interaction scenario described in our work revealed that both N- and C-terminal regions of αS represent binding interfaces for the studied compounds, a behavior that is mainly driven by the presence of negatively or positively charged substituents located at the periphery of the macrocycle. Binding modes of the tetrapyrrole ligands to αS are determined by the planarity and hydrophobicity of the aromatic ring system in the tetrapyrrolic molecule and/or the preferential affinity of the metal ion conjugated at the center of the macrocyclic ring. The different capability of phthalocyanines and meso-tetra (N-methyl-4-pyridyl) porphine tetrachloride ([HPrTPCl]) to modulate αS aggregation in vitro was reproduced in cell-based models of αS aggregation, demonstrating unequivocally that the modulation exerted by these compounds on amyloid assembly is a direct consequence of their interaction with the target protein.
聚集抑制剂的发现及其作用机制的阐明是减轻淀粉样蛋白形成毒性后果的关键。我们之前已经描述了对映体青霉胺四磺酸钠([Na(HPcTS)])对α-突触核蛋白(αS)的抗淀粉样蛋白形成作用机制,表明特定的芳香相互作用是抑制淀粉样蛋白组装的基础。在这里,我们研究了金属优先亲和力和外围取代基可能对四吡咯化合物对αS 聚集活性的影响。我们的实验室首次将生物无机化学和生物物理学领域的研究扩展到细胞生物学,使用成熟的基于细胞的模型来研究αS 聚集。我们的工作中描述的相互作用场景表明,αS 的 N-和 C-末端区域都代表了研究化合物的结合界面,这种行为主要是由位于大环外围的带负电荷或带正电荷的取代基引起的。四吡咯配体与αS 的结合模式取决于四吡咯分子中芳环系统的平面性和疏水性和/或与大环环中心共轭的金属离子的优先亲和力。在体外,对映体青霉胺和间四(4-吡啶基)卟啉四氯([HPrTPCl])调节αS 聚集的不同能力在基于细胞的αS 聚集模型中得到了重现,这明确证明了这些化合物对淀粉样蛋白组装的调节是它们与靶蛋白相互作用的直接结果。